Strategikon Pharma, developer of the novel clinical trial planning, budgeting, outsourcing and vendor management tool Clinical Maestro™, announced the commercial release of its Pharma (Sponsor) Edition SOURCE™ module for automating key processes in clinical...
New study suggests loosening strict comorbidity criteria would open trials to thousands of previously exempt patients Jan. 10, 2019 By Diane Mapes / Fred Hutch News Service How do you make cancer clinical trials available to more patients? A new study published today...
CYPRESS currently enrolling children aged 6-9 at clinical sites throughout the U.S. and Canada SightGlass Vision, Inc., a medical device company developing spectacle lenses to slow the progression of nearsightedness or myopia in children, today announced its...
Femasys, Inc., a medical technology company developing a platform of innovative in-office solutions for women’s healthcare today announced that the first 100 women in the BLOC pivotal clinical trial received the FemBloc® permanent contraceptive treatment. FemBloc is a...
ChemomAb, a clinical-stage biopharmaceutical company focused on the development of novel therapies for fibrotic-inflammatory diseases, announced dosing of the first patient in a Phase 1b repeated dose clinical trial with CM-101 in non-alcoholic fatty liver disease...
Email
Text